0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Hugh Y. Rienhoff, Jr.
Eikon Therapeutics
1 follower
Carisma Therapeutics
1 follower
insitro
6 followers
SpringWorks Therapeutics
6 followers
REVOLUTION Medicines
5 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Product School
5 followers
Inari
3 followers
Dyne Therapeutics
3 followers
Beta Bionics
3 followers
Explore companies